Gene Symbol | Gene ID | Gene Info |
---|---|---|
ISL2
|
ENSG00000159556.5 | ISL LIM homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_76628683_76628834 | ISL2 | 307 | 0.900622 | -0.64 | 6.3e-02 | Click! |
chr15_76627931_76628583 | ISL2 | 808 | 0.638054 | -0.50 | 1.7e-01 | Click! |
chr15_76629589_76629763 | ISL2 | 611 | 0.737067 | -0.35 | 3.5e-01 | Click! |
chr15_76630019_76630254 | ISL2 | 1071 | 0.521373 | -0.27 | 4.8e-01 | Click! |
chr15_76629117_76629510 | ISL2 | 248 | 0.925541 | -0.24 | 5.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr15_30112674_30113382 | 0.72 |
TJP1 |
tight junction protein 1 |
723 |
0.64 |
chr6_28616143_28617086 | 0.60 |
ENSG00000272278 |
. |
572 |
0.79 |
chr10_29010987_29011704 | 0.59 |
ENSG00000201001 |
. |
38387 |
0.14 |
chr9_14312608_14313176 | 0.58 |
NFIB |
nuclear factor I/B |
774 |
0.71 |
chr22_36231755_36232301 | 0.58 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
4237 |
0.32 |
chr2_9348603_9349207 | 0.56 |
ASAP2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
2011 |
0.46 |
chr8_127837007_127837644 | 0.50 |
ENSG00000212451 |
. |
153558 |
0.04 |
chr10_18629419_18629841 | 0.50 |
CACNB2 |
calcium channel, voltage-dependent, beta 2 subunit |
36 |
0.99 |
chr20_14316163_14316462 | 0.50 |
FLRT3 |
fibronectin leucine rich transmembrane protein 3 |
1942 |
0.4 |
chr4_41215270_41215769 | 0.49 |
APBB2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
956 |
0.59 |
chr6_28641788_28642196 | 0.49 |
ENSG00000272278 |
. |
25950 |
0.18 |
chr9_97812256_97812766 | 0.49 |
ENSG00000207563 |
. |
34979 |
0.12 |
chr21_34918443_34918594 | 0.48 |
GART |
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase |
2721 |
0.18 |
chr1_225117686_225118141 | 0.48 |
DNAH14 |
dynein, axonemal, heavy chain 14 |
529 |
0.87 |
chr13_93897456_93897607 | 0.48 |
GPC6 |
glypican 6 |
18436 |
0.29 |
chr4_77611462_77611724 | 0.47 |
AC107072.2 |
|
52817 |
0.12 |
chr11_131780111_131780399 | 0.47 |
NTM |
neurotrimin |
642 |
0.77 |
chr8_116675050_116675578 | 0.46 |
TRPS1 |
trichorhinophalangeal syndrome I |
1409 |
0.6 |
chr1_95005421_95005705 | 0.44 |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
1630 |
0.52 |
chr4_122686341_122686757 | 0.44 |
TMEM155 |
transmembrane protein 155 |
33 |
0.94 |
chr15_49716998_49717158 | 0.44 |
FGF7 |
fibroblast growth factor 7 |
1621 |
0.44 |
chr11_69454777_69455129 | 0.42 |
CCND1 |
cyclin D1 |
902 |
0.63 |
chr8_38855409_38855789 | 0.42 |
ADAM9 |
ADAM metallopeptidase domain 9 |
1094 |
0.34 |
chr3_149094469_149095370 | 0.41 |
TM4SF1-AS1 |
TM4SF1 antisense RNA 1 |
646 |
0.47 |
chr2_200446222_200446758 | 0.41 |
SATB2 |
SATB homeobox 2 |
110501 |
0.07 |
chr7_98970111_98970529 | 0.40 |
ARPC1B |
actin related protein 2/3 complex, subunit 1B, 41kDa |
1552 |
0.28 |
chr12_75784171_75784441 | 0.39 |
CAPS2 |
calcyphosine 2 |
375 |
0.6 |
chr6_169653692_169653887 | 0.39 |
THBS2 |
thrombospondin 2 |
350 |
0.92 |
chr17_35851874_35852313 | 0.39 |
DUSP14 |
dual specificity phosphatase 14 |
523 |
0.79 |
chr2_235861878_235862318 | 0.39 |
SH3BP4 |
SH3-domain binding protein 4 |
1378 |
0.62 |
chr21_16431010_16431483 | 0.38 |
NRIP1 |
nuclear receptor interacting protein 1 |
5880 |
0.3 |
chr20_35830256_35830797 | 0.38 |
MROH8 |
maestro heat-like repeat family member 8 |
22535 |
0.17 |
chr3_132315920_132316071 | 0.37 |
ACKR4 |
atypical chemokine receptor 4 |
86 |
0.98 |
chr21_39807445_39807798 | 0.37 |
ERG |
v-ets avian erythroblastosis virus E26 oncogene homolog |
62724 |
0.14 |
chrX_73069883_73070423 | 0.36 |
RP13-216E22.5 |
|
119167 |
0.06 |
chr15_59663421_59663716 | 0.36 |
FAM81A |
family with sequence similarity 81, member A |
1324 |
0.28 |
chr1_185704392_185704588 | 0.36 |
HMCN1 |
hemicentin 1 |
807 |
0.75 |
chr18_52495652_52496658 | 0.36 |
RAB27B |
RAB27B, member RAS oncogene family |
725 |
0.77 |
chr3_157822422_157822707 | 0.35 |
SHOX2 |
short stature homeobox 2 |
519 |
0.7 |
chr7_116141197_116141631 | 0.35 |
CAV2 |
caveolin 2 |
1580 |
0.29 |
chr10_33620140_33620362 | 0.35 |
NRP1 |
neuropilin 1 |
3059 |
0.34 |
chr7_80547175_80548098 | 0.35 |
SEMA3C |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
863 |
0.76 |
chr7_18550520_18550717 | 0.35 |
HDAC9 |
histone deacetylase 9 |
1682 |
0.51 |
chr8_25868117_25868310 | 0.35 |
EBF2 |
early B-cell factor 2 |
30791 |
0.24 |
chr12_78334931_78335200 | 0.35 |
NAV3 |
neuron navigator 3 |
24991 |
0.28 |
chr6_56111778_56112295 | 0.35 |
COL21A1 |
collagen, type XXI, alpha 1 |
199 |
0.97 |
chr1_99126586_99127126 | 0.35 |
SNX7 |
sorting nexin 7 |
380 |
0.93 |
chrX_114795565_114796048 | 0.34 |
PLS3 |
plastin 3 |
224 |
0.9 |
chr1_100111418_100111643 | 0.34 |
PALMD |
palmdelphin |
31 |
0.99 |
chr12_26112779_26113361 | 0.34 |
RASSF8-AS1 |
RASSF8 atnisense RNA 1 |
372 |
0.8 |
chr2_236410241_236410494 | 0.34 |
AGAP1-IT1 |
AGAP1 intronic transcript 1 (non-protein coding) |
4028 |
0.26 |
chr5_9540799_9541378 | 0.34 |
SEMA5A |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
5099 |
0.2 |
chr9_684288_685148 | 0.34 |
RP11-130C19.3 |
|
837 |
0.67 |
chr10_69831641_69832005 | 0.34 |
HERC4 |
HECT and RLD domain containing E3 ubiquitin protein ligase 4 |
2071 |
0.33 |
chr16_54407600_54408115 | 0.33 |
IRX3 |
iroquois homeobox 3 |
87182 |
0.09 |
chr5_66311217_66311678 | 0.33 |
MAST4 |
microtubule associated serine/threonine kinase family member 4 |
10964 |
0.24 |
chr7_28943782_28944337 | 0.33 |
CTB-113D17.1 |
|
75524 |
0.1 |
chr1_45083000_45083241 | 0.32 |
RNF220 |
ring finger protein 220 |
8878 |
0.17 |
chr13_24146066_24146217 | 0.32 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
1338 |
0.59 |
chr18_60385543_60385694 | 0.31 |
PHLPP1 |
PH domain and leucine rich repeat protein phosphatase 1 |
2935 |
0.28 |
chr3_33318777_33319866 | 0.31 |
FBXL2 |
F-box and leucine-rich repeat protein 2 |
353 |
0.91 |
chr13_76217437_76217800 | 0.31 |
LMO7 |
LIM domain 7 |
7159 |
0.18 |
chr21_17909068_17909746 | 0.31 |
ENSG00000207638 |
. |
2002 |
0.33 |
chr1_57041430_57041821 | 0.31 |
PPAP2B |
phosphatidic acid phosphatase type 2B |
3616 |
0.34 |
chr8_30243504_30243875 | 0.31 |
RBPMS-AS1 |
RBPMS antisense RNA 1 |
772 |
0.48 |
chr14_71067961_71068112 | 0.30 |
MED6 |
mediator complex subunit 6 |
652 |
0.7 |
chr22_36310772_36312004 | 0.30 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
23557 |
0.25 |
chr15_60683943_60684180 | 0.30 |
ANXA2 |
annexin A2 |
565 |
0.83 |
chr10_4719640_4719886 | 0.30 |
AKR1E2 |
aldo-keto reductase family 1, member E2 |
109058 |
0.07 |
chr13_38445031_38445182 | 0.30 |
TRPC4 |
transient receptor potential cation channel, subfamily C, member 4 |
544 |
0.83 |
chr9_74510609_74510876 | 0.30 |
ENSG00000200922 |
. |
6724 |
0.2 |
chr17_33391542_33391948 | 0.30 |
RFFL |
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase |
874 |
0.45 |
chr3_145876853_145877198 | 0.30 |
PLOD2 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 |
1754 |
0.42 |
chr14_45433796_45433989 | 0.30 |
FAM179B |
family with sequence similarity 179, member B |
2450 |
0.23 |
chr11_89027115_89027763 | 0.30 |
TYR |
tyrosinase |
116819 |
0.06 |
chr15_68574728_68574982 | 0.30 |
FEM1B |
fem-1 homolog b (C. elegans) |
2558 |
0.28 |
chr8_38030618_38031135 | 0.30 |
BAG4 |
BCL2-associated athanogene 4 |
3230 |
0.13 |
chr11_101983358_101983513 | 0.30 |
YAP1 |
Yes-associated protein 1 |
190 |
0.94 |
chr8_87317262_87317629 | 0.29 |
WWP1 |
WW domain containing E3 ubiquitin protein ligase 1 |
37522 |
0.18 |
chr1_178269315_178269642 | 0.29 |
RASAL2 |
RAS protein activator like 2 |
41128 |
0.2 |
chr13_38172411_38172686 | 0.29 |
POSTN |
periostin, osteoblast specific factor |
315 |
0.95 |
chr21_18376217_18376955 | 0.29 |
ENSG00000239023 |
. |
285269 |
0.01 |
chr1_230223080_230223231 | 0.29 |
GALNT2 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
20137 |
0.23 |
chr5_88178054_88178448 | 0.29 |
MEF2C |
myocyte enhancer factor 2C |
713 |
0.52 |
chr11_133990232_133990720 | 0.29 |
NCAPD3 |
non-SMC condensin II complex, subunit D3 |
47891 |
0.12 |
chr3_87036535_87037613 | 0.29 |
VGLL3 |
vestigial like 3 (Drosophila) |
2778 |
0.42 |
chr18_61554936_61555215 | 0.29 |
SERPINB2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
82 |
0.97 |
chr10_33620428_33620906 | 0.28 |
NRP1 |
neuropilin 1 |
2643 |
0.37 |
chr10_5005306_5005493 | 0.28 |
AKR1C1 |
aldo-keto reductase family 1, member C1 |
46 |
0.92 |
chr9_109625885_109626257 | 0.28 |
ZNF462 |
zinc finger protein 462 |
624 |
0.77 |
chr15_96897591_96898313 | 0.28 |
AC087477.1 |
Uncharacterized protein |
6535 |
0.18 |
chr4_57984994_57985389 | 0.27 |
IGFBP7 |
insulin-like growth factor binding protein 7 |
8640 |
0.18 |
chr13_76588981_76589230 | 0.27 |
ENSG00000243274 |
. |
119962 |
0.06 |
chr22_40592299_40592620 | 0.27 |
TNRC6B |
trinucleotide repeat containing 6B |
18513 |
0.24 |
chr18_6730820_6730971 | 0.27 |
ARHGAP28 |
Rho GTPase activating protein 28 |
853 |
0.47 |
chr14_92413096_92413399 | 0.27 |
FBLN5 |
fibulin 5 |
171 |
0.96 |
chr8_97507706_97507857 | 0.27 |
SDC2 |
syndecan 2 |
1545 |
0.51 |
chr9_117877804_117878113 | 0.27 |
TNC |
tenascin C |
2520 |
0.36 |
chr22_46933754_46934840 | 0.27 |
CELSR1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
1230 |
0.46 |
chr2_230138192_230138530 | 0.27 |
PID1 |
phosphotyrosine interaction domain containing 1 |
2360 |
0.4 |
chr10_5045552_5046386 | 0.27 |
AKR1C2 |
aldo-keto reductase family 1, member C2 |
83 |
0.93 |
chr4_26344236_26344574 | 0.27 |
RBPJ |
recombination signal binding protein for immunoglobulin kappa J region |
357 |
0.93 |
chr10_128249841_128250268 | 0.27 |
ENSG00000221717 |
. |
4421 |
0.3 |
chr6_116834038_116834189 | 0.26 |
TRAPPC3L |
trafficking protein particle complex 3-like |
607 |
0.55 |
chr11_121800761_121801203 | 0.26 |
ENSG00000252556 |
. |
74081 |
0.11 |
chr13_33858125_33858279 | 0.26 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
1690 |
0.4 |
chr16_82049841_82049992 | 0.26 |
SDR42E1 |
short chain dehydrogenase/reductase family 42E, member 1 |
4823 |
0.21 |
chr11_111849006_111849202 | 0.26 |
DIXDC1 |
DIX domain containing 1 |
1071 |
0.39 |
chr9_12777034_12777185 | 0.26 |
LURAP1L |
leucine rich adaptor protein 1-like |
2089 |
0.33 |
chr6_27182410_27182602 | 0.26 |
PRSS16 |
protease, serine, 16 (thymus) |
32974 |
0.13 |
chr3_105657205_105657471 | 0.26 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
68942 |
0.15 |
chr6_121763088_121763295 | 0.26 |
GJA1 |
gap junction protein, alpha 1, 43kDa |
6353 |
0.19 |
chr16_51185409_51185597 | 0.26 |
SALL1 |
spalt-like transcription factor 1 |
317 |
0.9 |
chr5_78808053_78808300 | 0.26 |
HOMER1 |
homer homolog 1 (Drosophila) |
441 |
0.86 |
chr14_62032902_62033075 | 0.26 |
RP11-47I22.3 |
Uncharacterized protein |
4326 |
0.24 |
chr2_188418561_188419245 | 0.26 |
AC007319.1 |
|
27 |
0.69 |
chr12_110720958_110721647 | 0.26 |
ATP2A2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
1816 |
0.41 |
chr5_3597777_3597928 | 0.26 |
IRX1 |
iroquois homeobox 1 |
1684 |
0.41 |
chr17_13498641_13498792 | 0.25 |
HS3ST3A1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
6528 |
0.28 |
chr4_157873991_157874142 | 0.25 |
PDGFC |
platelet derived growth factor C |
17989 |
0.21 |
chr12_91576064_91576215 | 0.25 |
DCN |
decorin |
290 |
0.94 |
chr13_79182716_79183828 | 0.25 |
POU4F1 |
POU class 4 homeobox 1 |
5599 |
0.19 |
chr6_21004300_21004557 | 0.25 |
ENSG00000252046 |
. |
10629 |
0.32 |
chr12_118628413_118628612 | 0.25 |
TAOK3 |
TAO kinase 3 |
156 |
0.96 |
chr5_78204137_78204521 | 0.25 |
ARSB |
arylsulfatase B |
77279 |
0.11 |
chr7_82072002_82072462 | 0.25 |
CACNA2D1 |
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
799 |
0.78 |
chr15_56207406_56207680 | 0.25 |
NEDD4 |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
309 |
0.92 |
chr7_55089056_55089207 | 0.25 |
EGFR |
epidermal growth factor receptor |
2320 |
0.44 |
chr7_77168081_77168577 | 0.25 |
PTPN12 |
protein tyrosine phosphatase, non-receptor type 12 |
943 |
0.69 |
chr1_65005729_65006114 | 0.25 |
ENSG00000264470 |
. |
39609 |
0.19 |
chr5_141701461_141701673 | 0.25 |
SPRY4 |
sprouty homolog 4 (Drosophila) |
2180 |
0.34 |
chr12_47470653_47470804 | 0.25 |
PCED1B |
PC-esterase domain containing 1B |
2658 |
0.29 |
chr15_83379003_83379154 | 0.25 |
AP3B2 |
adaptor-related protein complex 3, beta 2 subunit |
412 |
0.78 |
chr8_60538222_60538702 | 0.25 |
ENSG00000201763 |
. |
170018 |
0.04 |
chr16_24999320_24999715 | 0.25 |
ARHGAP17 |
Rho GTPase activating protein 17 |
27135 |
0.22 |
chr7_116169835_116170224 | 0.25 |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
3682 |
0.19 |
chr12_28120085_28120268 | 0.24 |
PTHLH |
parathyroid hormone-like hormone |
2251 |
0.33 |
chr4_182568542_182568740 | 0.24 |
ENSG00000251742 |
. |
187620 |
0.03 |
chr4_80572253_80572434 | 0.24 |
OR7E94P |
olfactory receptor, family 7, subfamily E, member 94 pseudogene |
63059 |
0.15 |
chr21_17792302_17792515 | 0.24 |
ENSG00000207638 |
. |
119001 |
0.06 |
chr5_121517177_121517861 | 0.24 |
CTC-441N14.1 |
|
25809 |
0.17 |
chr5_53530337_53530488 | 0.24 |
ARL15 |
ADP-ribosylation factor-like 15 |
75991 |
0.11 |
chr8_89289368_89289519 | 0.24 |
RP11-586K2.1 |
|
49622 |
0.16 |
chr5_92414668_92414956 | 0.24 |
ENSG00000237187 |
. |
343307 |
0.01 |
chr22_36231482_36231681 | 0.24 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
4684 |
0.32 |
chr4_89977525_89978081 | 0.24 |
FAM13A |
family with sequence similarity 13, member A |
508 |
0.85 |
chr5_55149615_55149792 | 0.24 |
IL31RA |
interleukin 31 receptor A |
345 |
0.89 |
chr2_151340168_151340387 | 0.24 |
RND3 |
Rho family GTPase 3 |
1619 |
0.57 |
chr9_89952337_89952906 | 0.24 |
ENSG00000212421 |
. |
77256 |
0.11 |
chr3_54897831_54897982 | 0.24 |
CACNA2D3-AS1 |
CACNA2D3 antisense RNA 1 |
37376 |
0.21 |
chr9_14096707_14097036 | 0.24 |
NFIB |
nuclear factor I/B |
83920 |
0.11 |
chr9_21688149_21688723 | 0.24 |
ENSG00000244230 |
. |
10877 |
0.24 |
chr8_107738861_107739281 | 0.23 |
OXR1 |
oxidation resistance 1 |
658 |
0.71 |
chr5_120114861_120115414 | 0.23 |
ENSG00000222609 |
. |
68602 |
0.14 |
chr5_52302561_52302712 | 0.23 |
CTD-2175A23.1 |
|
16528 |
0.2 |
chr8_107738582_107738843 | 0.23 |
OXR1 |
oxidation resistance 1 |
299 |
0.9 |
chr3_150131286_150131437 | 0.23 |
TSC22D2 |
TSC22 domain family, member 2 |
2565 |
0.39 |
chr2_164590425_164590732 | 0.23 |
FIGN |
fidgetin |
1939 |
0.52 |
chr13_76346341_76346549 | 0.23 |
LMO7 |
LIM domain 7 |
11648 |
0.26 |
chr9_111206334_111206588 | 0.23 |
ENSG00000222512 |
. |
85252 |
0.11 |
chr18_51675978_51676321 | 0.23 |
ENSG00000221058 |
. |
63123 |
0.12 |
chr9_93732509_93732660 | 0.23 |
SYK |
spleen tyrosine kinase |
142814 |
0.05 |
chr3_185539129_185539363 | 0.23 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
397 |
0.89 |
chr1_156092284_156092708 | 0.23 |
LMNA |
lamin A/C |
3455 |
0.14 |
chr20_57086742_57086893 | 0.23 |
APCDD1L |
adenomatosis polyposis coli down-regulated 1-like |
3136 |
0.31 |
chr8_59027426_59027596 | 0.23 |
FAM110B |
family with sequence similarity 110, member B |
120398 |
0.07 |
chr13_41220263_41220414 | 0.23 |
FOXO1 |
forkhead box O1 |
20396 |
0.22 |
chr3_12235413_12235694 | 0.23 |
TIMP4 |
TIMP metallopeptidase inhibitor 4 |
34702 |
0.2 |
chr14_68466898_68467139 | 0.23 |
CTD-2566J3.1 |
|
129895 |
0.05 |
chr20_55207246_55207474 | 0.22 |
TFAP2C |
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) |
1422 |
0.37 |
chr2_43744394_43744545 | 0.22 |
THADA |
thyroid adenoma associated |
53185 |
0.14 |
chr8_125259601_125259830 | 0.22 |
ENSG00000206724 |
. |
13172 |
0.25 |
chr1_120191467_120191618 | 0.22 |
ZNF697 |
zinc finger protein 697 |
1146 |
0.52 |
chr15_96878465_96878729 | 0.22 |
ENSG00000222651 |
. |
2107 |
0.24 |
chr14_71022448_71023169 | 0.22 |
ADAM20 |
ADAM metallopeptidase domain 20 |
21076 |
0.17 |
chr22_36232810_36232961 | 0.22 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
3380 |
0.35 |
chr6_85823864_85824548 | 0.22 |
NT5E |
5'-nucleotidase, ecto (CD73) |
335603 |
0.01 |
chr1_150253572_150253809 | 0.22 |
C1orf51 |
chromosome 1 open reading frame 51 |
1263 |
0.25 |
chr18_42313149_42313495 | 0.22 |
SETBP1 |
SET binding protein 1 |
36193 |
0.24 |
chr4_157691847_157691998 | 0.22 |
RP11-154F14.2 |
|
70589 |
0.11 |
chr14_29859562_29859789 | 0.22 |
ENSG00000257522 |
. |
11813 |
0.29 |
chr6_5471426_5471612 | 0.22 |
RP1-232P20.1 |
|
13211 |
0.27 |
chrX_78002931_78003376 | 0.22 |
LPAR4 |
lysophosphatidic acid receptor 4 |
72 |
0.99 |
chr1_234793534_234793917 | 0.22 |
IRF2BP2 |
interferon regulatory factor 2 binding protein 2 |
48454 |
0.13 |
chrX_114829080_114829277 | 0.22 |
PLS3 |
plastin 3 |
1313 |
0.48 |
chr5_87957336_87957520 | 0.22 |
ENSG00000245526 |
. |
5329 |
0.23 |
chr5_154033985_154034136 | 0.22 |
ENSG00000221552 |
. |
31276 |
0.14 |
chr2_36581700_36582677 | 0.22 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
881 |
0.74 |
chr3_127898089_127898282 | 0.22 |
RUVBL1 |
RuvB-like AAA ATPase 1 |
25428 |
0.15 |
chr5_32991481_32991632 | 0.22 |
AC026703.1 |
|
202611 |
0.03 |
chr12_131201177_131201518 | 0.22 |
RIMBP2 |
RIMS binding protein 2 |
521 |
0.86 |
chr18_53090404_53090609 | 0.22 |
TCF4 |
transcription factor 4 |
763 |
0.7 |
chr21_29233086_29233318 | 0.22 |
ENSG00000251894 |
. |
882328 |
0.0 |
chr2_133061942_133062584 | 0.22 |
ENSG00000221288 |
. |
47610 |
0.14 |
chr2_43134028_43134374 | 0.22 |
HAAO |
3-hydroxyanthranilate 3,4-dioxygenase |
114469 |
0.06 |
chr9_98188423_98189086 | 0.22 |
PTCH1 |
patched 1 |
54013 |
0.12 |
chr15_88020923_88021173 | 0.21 |
ENSG00000207150 |
. |
3528 |
0.4 |
chr7_55166552_55166703 | 0.21 |
EGFR |
epidermal growth factor receptor |
10789 |
0.29 |
chr4_112951015_112951190 | 0.21 |
C4orf32 |
chromosome 4 open reading frame 32 |
115451 |
0.06 |
chrX_10709343_10709494 | 0.21 |
MID1 |
midline 1 (Opitz/BBB syndrome) |
63639 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.4 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.5 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.5 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.3 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.1 | 0.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.3 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.3 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.4 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.1 | 0.2 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.3 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.1 | 0.3 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.3 | GO:1903672 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.2 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.2 | GO:0035583 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.2 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.2 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.0 | 0.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.0 | GO:0060594 | mammary gland specification(GO:0060594) |
0.0 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.2 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.0 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.1 | GO:0032353 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.0 | 0.1 | GO:2001280 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.0 | 0.7 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.4 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.2 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.0 | 0.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0045198 | polarized epithelial cell differentiation(GO:0030859) establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.2 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.3 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.1 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.5 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.1 | GO:1903077 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.1 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.1 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.0 | 0.1 | GO:1903054 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.4 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.2 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.3 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.0 | 0.0 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.0 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.0 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.5 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.0 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.3 | GO:0048538 | thymus development(GO:0048538) |
0.0 | 0.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.0 | GO:0051284 | negative regulation of ion transmembrane transporter activity(GO:0032413) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.0 | 0.2 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.0 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.0 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.0 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.0 | 0.0 | GO:0010664 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.0 | GO:0021825 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.0 | 0.0 | GO:0046639 | negative regulation of alpha-beta T cell differentiation(GO:0046639) |
0.0 | 0.2 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0001885 | endothelial cell development(GO:0001885) |
0.0 | 0.1 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.0 | 0.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.4 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.2 | GO:0048821 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 0.2 | GO:0006949 | syncytium formation(GO:0006949) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0001660 | fever generation(GO:0001660) |
0.0 | 0.1 | GO:0032933 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.0 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.0 | GO:0060592 | mammary gland formation(GO:0060592) |
0.0 | 0.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.0 | GO:0060913 | endocardium development(GO:0003157) endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) cardiac cell fate determination(GO:0060913) |
0.0 | 0.1 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.3 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.2 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.0 | GO:0031223 | auditory behavior(GO:0031223) |
0.0 | 0.0 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.1 | GO:0090114 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) |
0.0 | 0.0 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.0 | 0.0 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.0 | 0.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.0 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.0 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.0 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.0 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.0 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.6 | GO:0007043 | cell-cell junction assembly(GO:0007043) |
0.0 | 0.0 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.0 | 0.0 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.1 | GO:0090494 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.1 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.0 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.8 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.0 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.0 | GO:0060439 | trachea morphogenesis(GO:0060439) |
0.0 | 0.1 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.0 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 0.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 0.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.0 | 0.1 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.0 | 0.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.0 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.0 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.0 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.0 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.0 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.0 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.0 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.0 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.2 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.0 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.0 | 0.2 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.0 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.0 | 0.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.0 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.6 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.0 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.1 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.3 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.0 | 0.0 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.0 | 0.0 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.4 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 0.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.0 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.0 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.0 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 1.0 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.2 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 0.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.5 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.2 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 1.1 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.0 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.3 | GO:0044420 | extracellular matrix component(GO:0044420) |
0.0 | 0.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.8 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.2 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.0 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.0 | GO:0070062 | extracellular organelle(GO:0043230) extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.0 | 0.2 | GO:0005902 | microvillus(GO:0005902) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.5 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.4 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.3 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.2 | GO:0004083 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.5 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.0 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.0 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.2 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.9 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.1 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.0 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 1.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.6 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.5 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.7 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 1.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.0 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |